Adnan Said, MD
Hepatology · Madison, WINPI 1669433454
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $136,535 of the $156,426 with a category attached, or 87.3%. 7 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 50.3% of the total. 2025 is the largest year on record at $71,680, more than ten times the $2,884 reported in 2019.
Across 99 payments — averaging $1580.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$79K
- Madrigal Pharmaceuticals$37K
- Novo Nordisk$36K
- Gilead$3K
- Intercept Pharmaceuticals, Inc.$2K
- Lantheus Medical Imaging, Inc.$350
- plus $120 from 1 others
Across 39 payments — averaging $3809.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$119K
- Intercept Pharma Europe Ltd.$20K
- Boehringer Ingelheim International GmbH$9K
What the payments were for
- Consulting fees$11,7257%
- Speaking & faculty fees$136,53587%
- Travel & lodging$5,5144%
- Food & beverage$2,5872%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 42 | $78,614 |
| Madrigal Pharmaceuticals | 22 | $36,575 |
| Novo Nordisk | 17 | $36,172 |
| Gilead | 5 | $2,884 |
| Intercept Pharmaceuticals, Inc. | 10 | $1,711 |
| Lantheus Medical Imaging, Inc. | 1 | $350 |
| Cook Medical LLC | 2 | $120 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TERLIVAZ$78,298
- REZDIFFRA$35,203
- Wegovy$33,280
- Vemlidy$2,749
- RESMETIROM$136
How this compares
Too few hepatology providers in Wisconsinto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 36 | $114,039 |
| Envarsus XrTacrolimus | 33 | $23,667 |
| Mycophenolic AcidMycophenolate Sodium | 92 | $22,559 |
| Everolimus | 13 | $22,092 |
| Ursodiol | 172 | $19,753 |
| Tacrolimus | 225 | $14,408 |
| Sirolimus | 37 | $6,365 |
| Mycophenolate Mofetil | 46 | $2,530 |
| Azathioprine | 27 | $1,338 |
| Pantoprazole Sodium | 55 | $715 |
| Entecavir | 19 | $645 |
| Prednisone | 125 | $611 |
| Hydroxyzine Hcl | 12 | $389 |
| Carvedilol | 45 | $227 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $186 |
Paid to pharmacies, not to this prescriber.
Other hepatology in Madison
- Michael LuceyMadison$420
- Nicole BoschuetzMadison$350
- Margarita GermanMadison$249
- Parul AgarwalMadison$150
- Phaedra TachtatzisMilwaukee$493
- Siddesh BesurMilwaukee$57
- Shiva KumarMilwaukee$43
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.